These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 21845054)
1. Current and emerging treatments for the management of myasthenia gravis. Sathasivam S Ther Clin Risk Manag; 2011; 7():313-23. PubMed ID: 21845054 [TBL] [Abstract][Full Text] [Related]
2. Maintenance immunosuppression in myasthenia gravis. Gotterer L; Li Y J Neurol Sci; 2016 Oct; 369():294-302. PubMed ID: 27653912 [TBL] [Abstract][Full Text] [Related]
3. Maintenance immunosuppression in myasthenia gravis, an update. Morren J; Li Y J Neurol Sci; 2020 Mar; 410():116648. PubMed ID: 31901719 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic options in autoimmune myasthenia gravis. García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383 [TBL] [Abstract][Full Text] [Related]
5. Autoimmune Myasthenia Gravis: Recommendations for Treatment and Immunologic Modulation. Juel VC; Massey JM Curr Treat Options Neurol; 2005 Jan; 7(1):3-14. PubMed ID: 15610702 [TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis: an update for the clinician. Sieb JP Clin Exp Immunol; 2014 Mar; 175(3):408-18. PubMed ID: 24117026 [TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis: options and timing of immunomodulatory treatment. Spring PJ; Spies JM BioDrugs; 2001; 15(3):173-83. PubMed ID: 11437683 [TBL] [Abstract][Full Text] [Related]